| Jessica Jocelyn, MED, CF-SLP | |
|
6727 Meritmoor Circle, Orlando, FL 32818 | |
| (321) 310-6371 | |
| Not Available |
| Full Name | Jessica Jocelyn |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 6727 Meritmoor Circle, Orlando, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013389659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SZ7385 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Jocelyn, MED, CF-SLP 6727 Meritmoor Circle, Orlando, FL 32818 Ph: (321) 310-6371 | Jessica Jocelyn, MED, CF-SLP 6727 Meritmoor Circle, Orlando, FL 32818 Ph: (321) 310-6371 |
News Archive
College students who participate in fun, peer-directed activities that openly and honestly address mental illness are significantly less likely to stigmatize people with these conditions, according to a new study led by researchers at Indiana University.
For women who have undergone mastectomy for breast cancer, breast reconstruction using the abdominal "DIEP flap" provides good long-term quality of life (QOL)—similar to that of women without breast cancer, reports a study in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.
› Verified 1 days ago
Ms. Yentel C. Moses, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5210 Vatican Ave, Orlando, FL 32810 Phone: 954-494-5468 Fax: 954-989-7981 | |
Michelle Bartlett, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11602 Lake Underhill Rd Ste 129, Orlando, FL 32825 Phone: 239-298-6397 | |
Sonya Persaud, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7950 Lake Underhill Rd, Orlando, FL 32822 Phone: 407-601-6888 | |
Keissy Lorini, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12377 S Orange Blossom Trl, Orlando, FL 32837 Phone: 407-857-1212 | |
Regan Brackin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1239 Mount Vernon St, Orlando, FL 32803 Phone: 407-810-2773 Fax: 407-867-6203 | |
Mrs. Rebecca L Burt, MA, CCC/SLP, NBCT Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Derby Glen Dr, Orlando, FL 32837 Phone: 407-641-0808 Fax: 407-812-4358 | |
Dr. Charlotte M Harvey, EDD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12424 Research Pkwy, Suite 155, Orlando, FL 32826 Phone: 407-882-0468 Fax: 407-249-4774 |